Literature DB >> 23256520

Prevalence, perceptions, and correlates of pediatric HIV disclosure in an HIV treatment program in Kenya.

Grace C John-Stewart1, Grace Wariua, Kristin M Beima-Sofie, Barbra A Richardson, Carey Farquhar, Elizabeth Maleche-Obimbo, Dorothy Mbori-Ngacha, Dalton Wamalwa.   

Abstract

Disclosure to HIV-infected children regarding their diagnosis is important as expanding numbers of HIV-infected children attain adolescence and may become sexually active. In order to define correlates of pediatric disclosure and facilitate development of models for disclosure, we conducted a cross-sectional survey of primary caregivers of HIV-1 infected children aged 6-16 years attending a pediatric HIV treatment program in Nairobi, Kenya. We conducted focus group discussions with a subset of caregivers to further refine perceptions of disclosure. Among 271 caregiver/child dyads in the cross-sectional survey, median child age was 9 years (interquartile range: 7-12 years). Although 79% of caregivers believed children should know their HIV status, the prevalence of disclosure to the child was only 19%. Disclosure had been done primarily by health workers (52%) and caregivers (33%). Caregivers reported that 5 of the 52 (10%) who knew their status were accidentally disclosed to. Caregivers of older children (13 vs. 8 years; p<0.001), who were HIV-infected and had disclosed their own HIV status to the child (36% vs. 4%; p=0.003), or who traveled frequently (29% vs. 16%, p=0.03) were more likely to have disclosed. Children who had been recently hospitalized (25% vs. 44%, p=0.03) were less likely to know their status, and caregivers with HIV were less likely to have disclosed (p=0.03). Reasons for disclosure included medication adherence, curiosity or illness while reasons for nondisclosure included age and fear of inadvertent disclosure. Our study found that disclosure rates in this Kenyan setting are lower than observed rates in the USA and Europe but consistent with rates from other resource-limited settings. Given these low rates of disclosure and the potential benefits of disclosure, strategies promoting health worker trainings and caregiver support systems for disclosure may benefit children with HIV.

Entities:  

Mesh:

Year:  2012        PMID: 23256520      PMCID: PMC3626761          DOI: 10.1080/09540121.2012.749333

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  33 in total

Review 1.  Disclosure of HIV diagnosis to children: when, where, why, and how.

Authors:  A C Gerson; M Joyner; P Fosarelli; A Butz; L Wissow; S Lee; P Marks; N Hutton
Journal:  J Pediatr Health Care       Date:  2001 Jul-Aug       Impact factor: 1.812

2.  Communication of the cancer diagnosis to pediatric patients: impact on long-term adjustment.

Authors:  L A Slavin; J E O'Malley; G P Koocher; D J Foster
Journal:  Am J Psychiatry       Date:  1982-02       Impact factor: 18.112

3.  Patterns of disclosure of HIV status to infected children in a Sub-Saharan African setting.

Authors:  Lara M E Vaz; Suzanne Maman; Eugenia Eng; Oscar A Barbarin; Tomi Tshikandu; Frieda Behets
Journal:  J Dev Behav Pediatr       Date:  2011-05       Impact factor: 2.225

4.  Diagnosis disclosure in HIV-infected Thai children.

Authors:  Vitharon Boon-Yasidhi; Uraporn Kottapat; Yuitiang Durier; Nottasorn Plipat; Wanatpreeya Phongsamart; Kulkanya Chokephaibulkit; Nirun Vanprapar
Journal:  J Med Assoc Thai       Date:  2005-11

5.  Factors associated with parents' decision to disclose their HIV diagnosis to their children.

Authors:  L S Wiener; H B Battles; N E Heilman
Journal:  Child Welfare       Date:  1998 Mar-Apr

Review 6.  Disclosure of an HIV diagnosis to children: history, current research, and future directions.

Authors:  Lori Wiener; Claude Ann Mellins; Stephanie Marhefka; Haven B Battles
Journal:  J Dev Behav Pediatr       Date:  2007-04       Impact factor: 2.225

7.  Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana.

Authors:  Stacey Kallem; Lorna Renner; Musie Ghebremichael; Elijah Paintsil
Journal:  AIDS Behav       Date:  2011-08

Review 8.  Research on families and pediatric human immunodeficiency virus disease: a review and needed directions.

Authors:  F L Cohen
Journal:  J Dev Behav Pediatr       Date:  1994-06       Impact factor: 2.225

9.  Families affected by pediatric acquired immunodeficiency syndrome: sources of stress and coping.

Authors:  C A Mellins; A A Ehrhardt
Journal:  J Dev Behav Pediatr       Date:  1994-06       Impact factor: 2.225

10.  Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.

Authors:  Anne M Butler; Paige L Williams; Lois C Howland; Deborah Storm; Nancy Hutton; George R Seage
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

View more
  29 in total

1.  Growing-up just like everyone else: key components of a successful pediatric HIV disclosure intervention in Namibia.

Authors:  Laura Brandt; Kristin Beima-Sofie; Ndapewa Hamunime; Mark Shepard; Larissa Ferris; Paulina Ingo; Grace John-Stewart; Gabrielle O'Malley
Journal:  AIDS       Date:  2015-06       Impact factor: 4.177

2.  Implementation and Operational Research: Active Referral of Children of HIV-Positive Adults Reveals High Prevalence of Undiagnosed HIV.

Authors:  Anjuli D Wagner; Cyrus Mugo; Irene N Njuguna; Elizabeth Maleche-Obimbo; Kenneth Sherr; Irene W Inwani; James P Hughes; Dalton C Wamalwa; Grace C John-Stewart; Jennifer A Slyker
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

3.  Pilot evaluation of a standardized patient actor training intervention to improve HIV care for adolescents and young adults in Kenya.

Authors:  Cyrus Mugo; Kate Wilson; Anjuli D Wagner; Irene W Inwani; Kevin Means; David Bukusi; Jennifer Slyker; Grace John-Stewart; Barbra A Richardson; Margaret Nduati; Helen Moraa; Dalton Wamalwa; Pamela Kohler
Journal:  AIDS Care       Date:  2019-02-27

4.  Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study.

Authors:  Anjuli D Wagner; Gabrielle OʼMalley; Olivia Firdawsi; Cyrus Mugo; Irene N Njuguna; Elizabeth Maleche-Obimbo; Irene W Inwani; Dalton C Wamalwa; Grace C John-Stewart; Jennifer A Slyker
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

5.  Factors affecting disclosure of serostatus to children attending Jinja Hospital Paediatric HIV clinic, Uganda.

Authors:  Sophie Namasopo-Oleja M; Danstan Bagenda; Elizabeth Ekirapa-Kiracho
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

6.  Caregivers' intentions to disclose HIV diagnosis to children living with HIV in South Africa: a theory-based approach.

Authors:  John B Jemmott; G Anita Heeren; Lulama Sidloyi; C Show Marange; Joanne C Tyler; Zolani Ngwane
Journal:  AIDS Behav       Date:  2014-06

Review 7.  A model of caregiver paediatric HIV disclosure decision-making.

Authors:  Michael Evangeli; Ashraf Kagee
Journal:  Psychol Health Med       Date:  2015-06-29       Impact factor: 2.423

8.  Disclosure and Clinical Outcomes Among Young Adolescents Living With HIV in Kenya.

Authors:  Bernadette Ngeno; Anthony Waruru; Irene Inwani; Lucy Nganga; Evelyn Ngugi Wangari; Abraham Katana; Anthony Gichangi; Ann Mwangi; Irene Mukui; George W Rutherford
Journal:  J Adolesc Health       Date:  2018-10-25       Impact factor: 5.012

9.  Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status.

Authors:  Pamela M Murnane; Stacy-Lee Sigamoney; Francoise Pinillos; Stephanie Shiau; Renate Strehlau; Faeezah Patel; Afaaf Liberty; Elaine J Abrams; Stephen Arpadi; Ashraf Coovadia; Avy Violari; Louise Kuhn
Journal:  AIDS Care       Date:  2016-08-29

10.  Using health provider insights to inform pediatric HIV disclosure: a qualitative study and practice framework from Kenya.

Authors:  Kristin Beima-Sofie; Grace John-Stewart; Brandi Shah; Dalton Wamalwa; Elizabeth Maleche-Obimbo; Maureen Kelley
Journal:  AIDS Patient Care STDS       Date:  2014-09-12       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.